RCM
TMO icon

Regency Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Regency Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,133
Closed -$2.97M – 76
2025
Q4 		$2.97M Sell
5,133
-425
-8% -$240K 1.24% 29
2025
Q3 		$2.7M Sell
5,558
-2,271
-29% -$1.06M 1.28% 30
2025
Q2 		$3.17M Sell
7,829
-2,145
-22% -$897K 1.67% 22
2025
Q1 		$4.96M Buy
9,974
+2,860
+40% +$1.55M 2.97% 13
2024
Q4 		$3.7M Buy
+7,114
New +$3.91M 2% 22
2024
Q1 		– Sell
-4,571
Closed -$2.43M – 57
2023
Q4 		$2.43M Sell
4,571
-109
-2% -$52.8K 1.63% 25
2023
Q3 		$2.37M Sell
4,680
-362
-7% -$193K 2.01% 18
2023
Q2 		$2.63M Buy
5,042
+79
+2% +$42.6K 2.29% 15
2023
Q1 		$2.86M Sell
4,963
-337
-6% -$190K 3.46% 11
2022
Q4 		$2.92M Sell
5,300
-151
-3% -$80K 3.35% 12
2022
Q3 		$2.77M Sell
5,451
-84
-2% -$47K 3.39% 12
2022
Q2 		$3.01M Sell
5,535
-1,929
-26% -$1.06M 3.23% 15
2022
Q1 		$4.41M Buy
7,464
+341
+5% +$196K 3.2% 9
2021
Q4 		$4.75M Buy
7,123
+1,700
+31% +$1.06M 3.02% 10
2021
Q3 		$3.1M Buy
5,423
+183
+3% +$100K 2.18% 14
2021
Q2 		$2.64M Buy
5,240
+1,617
+45% +$763K 2% 14
2021
Q1 		$1.65M Buy
+3,623
New +$1.73M 1.74% 19

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Regency Capital Management's TMO Position: Q1 2026 in Review

Regency Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 5,133 shares — an estimated $2.97M sold.

Regency Capital Management first reported a position in TMO in Q1 2021 and held it in 17 quarters. The position peaked at $4.96M in Q1 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Regency Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Regency Capital Management sold 5,133 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.97M.
  • Regency Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and held it in 17 quarters.
  • Regency Capital Management's Thermo Fisher Scientific position peaked at $4.96M in Q1 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Regency Capital Management's 13F filing for Q1 2026, filed 5 May 2026.